HARBOURVEST PARTNERS LLC - KALA PHARMACEUTICALS INC ownership

KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 132 filers reported holding KALA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.74 and the average weighting 0.1%.

Quarter-by-quarter ownership
HARBOURVEST PARTNERS LLC ownership history of KALA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2020$872,000
+138.3%
99,1860.0%0.42%
+178.8%
Q4 2019$366,000
-2.9%
99,1860.0%0.15%
-3.8%
Q3 2019$377,000
-70.2%
99,186
-50.0%
0.16%
-33.8%
Q2 2019$1,266,000
+54.4%
198,372
+100.0%
0.24%
-18.3%
Q1 2019$820,000
+69.1%
99,1860.0%0.29%
+26.1%
Q4 2018$485,000
-49.2%
99,1860.0%0.23%
-73.3%
Q3 2018$955,00099,1860.86%
Other shareholders
KALA PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Vahanian & Associates Financial Planning Inc. 181,384$54,0000.23%
Samsara BioCapital, LLC 601,162$180,0000.05%
Board of Trustees of The Leland Stanford Junior University 688,701$207,0000.01%
Matisse Capital 36,800$11,0000.01%
Knights of Columbus Asset Advisors LLC 120,841$36,0000.00%
Covestor Ltd 11,972$4,0000.00%
Ergoteles LLC 219,461$66,0000.00%
Virtu Financial LLC 74,636$22,0000.00%
IPG Investment Advisors LLC 14,300$4,0000.00%
Aquatic Capital Management LLC 13,200$4,0000.00%
View complete list of KALA PHARMACEUTICALS INC shareholders